S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen

NCT04912076 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Birch Pollen Allergy
Allergic Rhinoconjunctivitis

Interventions

DRUG: BM41
OTHER: Placebo
DRUG: ALK Alutard SQ Betula verrucosa

Sponsor

Odense University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]